Recent Advances in Our Knowledge of mCRC Tumor Biology and Genetics: A Focus on Targeted Therapy Development

Metastatic colorectal cancer (mCRC) remains a highly lethal malignancy although considerable progress has resulted from characterizing molecular alterations such as RAS mutation status and extent of microsatellite instability (MSI) to guide optimal use of available therapies. The availability of gen...

Descripción completa

Detalles Bibliográficos
Autor principal: Gmeiner, William H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007558/
https://www.ncbi.nlm.nih.gov/pubmed/33790575
http://dx.doi.org/10.2147/OTT.S242224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007558/
https://www.ncbi.nlm.nih.gov/pubmed/33790575
http://dx.doi.org/10.2147/OTT.S242224

Ejemplares similares